Session type Topic Cancer and Palliative Care Abstract title SCORING SYSTEM FOR BREAKTHROUGH-PAIN LIKELIHOOD IN CANCER PATIENTS: AN IMPACT STUDY Objectives: Breakthrough Cancer pain (BTcP) shows variable prevalence and challenging management. We report the preliminary results of an impact multicenter study with a novel Scoring System (SS) based on a validated diagnostic/prognostic tool, the IQ-BTP1,2, for BTcP recognition and likelihood (High, Intermediate, Low). Methods: The IQ-BTP SS was administered at 3 consecutive visits to n=100 patients. Other studied variables were: demographics, disease related information, pain therapy, Brief Pain Inventory and, physician concordance with and appreciation of the SS. We planned to establish among patients with potential BTcP the proportions of its High, Intermediate and Low likelihood and the feasibility/reliability of the SS. Results: The majority of the patients were correctly classified as potentially having (or not having) BTcP. In Visit #1, 2 and 3, respectively, ‘potential BTcP’ was found in 40, 43 and 24% of the patients with, respectively, high (48, 33 and 46%), intermediate (38, 51 and 50%) and low (15, 16 and 8%) likelihood. Over 90% of physicians reported that the SS was feasible and very helpful in diagnosing and managing BTcP. Conclusions: The IQ-BTP with its SS and with adequate feasibility enables the detection of potential-BTP and its likelihood. The latter has significant relevance to BTcP epidemiology and management. Bibliography 1. Samolsky Dekel BG et al. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients.Clin Neurol Neurosurg. 2016 Feb;141:23-9. 2. Samolsky Dekel BG et al. Development and performance of a diagnostic/prognostic scoring system for breakthrough pain. J Pain Res. 2017 May;31;10:1327-1335. Keywords Breakthrough pain scoring system likelihood cancer pain BTcP IQ-BTP Brief Pain Inventory
SCORING SYSTEM FOR BREAKTHROUGH-PAIN LIKELIHOOD IN CANCER PATIENTS: AN IMPACT STUDY / B.G. Samolsky Dekel, M.C. Sorella, A. Gori, A. Vasarri, R.M. Melotti. - In: PAIN PRACTICE. - ISSN 1530-7085. - STAMPA. - 18:S1(2018), pp. WIP18-0329.49-WIP18-0329.50. (Intervento presentato al convegno 9th World Congress of the World Institute of Pain (WIP) April 2018 tenutosi a Dublin (IR) nel 09-12 May 2018).
SCORING SYSTEM FOR BREAKTHROUGH-PAIN LIKELIHOOD IN CANCER PATIENTS: AN IMPACT STUDY
B. G. Samolsky Dekel
;M. C. Sorella;A. Gori;A. Vasarri;R. M. Melotti
2018
Abstract
Session type Topic Cancer and Palliative Care Abstract title SCORING SYSTEM FOR BREAKTHROUGH-PAIN LIKELIHOOD IN CANCER PATIENTS: AN IMPACT STUDY Objectives: Breakthrough Cancer pain (BTcP) shows variable prevalence and challenging management. We report the preliminary results of an impact multicenter study with a novel Scoring System (SS) based on a validated diagnostic/prognostic tool, the IQ-BTP1,2, for BTcP recognition and likelihood (High, Intermediate, Low). Methods: The IQ-BTP SS was administered at 3 consecutive visits to n=100 patients. Other studied variables were: demographics, disease related information, pain therapy, Brief Pain Inventory and, physician concordance with and appreciation of the SS. We planned to establish among patients with potential BTcP the proportions of its High, Intermediate and Low likelihood and the feasibility/reliability of the SS. Results: The majority of the patients were correctly classified as potentially having (or not having) BTcP. In Visit #1, 2 and 3, respectively, ‘potential BTcP’ was found in 40, 43 and 24% of the patients with, respectively, high (48, 33 and 46%), intermediate (38, 51 and 50%) and low (15, 16 and 8%) likelihood. Over 90% of physicians reported that the SS was feasible and very helpful in diagnosing and managing BTcP. Conclusions: The IQ-BTP with its SS and with adequate feasibility enables the detection of potential-BTP and its likelihood. The latter has significant relevance to BTcP epidemiology and management. Bibliography 1. Samolsky Dekel BG et al. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients.Clin Neurol Neurosurg. 2016 Feb;141:23-9. 2. Samolsky Dekel BG et al. Development and performance of a diagnostic/prognostic scoring system for breakthrough pain. J Pain Res. 2017 May;31;10:1327-1335. Keywords Breakthrough pain scoring system likelihood cancer pain BTcP IQ-BTP Brief Pain InventoryI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
